
Pharmacally
Biliary Atresia
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Biliary Atresia
Clinical TrialsIpsen’s Phase 3 BOLD Trial of Bylvay Fails to Improve Native Liver Survival in Biliary AtresiaIpsen reported that the Phase 3 BOLD trial of Bylvay (odevixibat) failed to improve native liver survival versus placebo in children with biliary atresia following Kasai hepatoportoenterostomy.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.